Headquarters
Adelaide, Australia
Private and Government Funding Secured*
Employees
Preclinical studies completed
FIH study commenced 2023
International KOL Clinical Advisors
USA, UK, DK, CA, FR, AUS
Foundational Patent Granted
22 claims
Patents filed
* Supported by a grant of more than $650,000 through the South Australian Government Research and Innovation Fund
